tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EDIT Stock Latest News

Editas announces preclinical data from in vivo gene editing medicines
The FlyEditas announces preclinical data from in vivo gene editing medicines
1d ago
EDIT
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
PremiumPress Releases
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
1d ago
EDIT
Editas Medicine price target lowered to $15 from $16 at Citi
PremiumThe Fly
Editas Medicine price target lowered to $15 from $16 at Citi
2d ago
EDIT
Editas Medicine price target lowered to $9 from $11 at Barclays
PremiumThe Fly
Editas Medicine price target lowered to $9 from $11 at Barclays
2d ago
EDIT
Editas Medicine upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
Editas Medicine upgraded to Equal Weight from Underweight at Morgan Stanley
3d ago
EDIT
Editas Medicine reports Q1 EPS (76c), consensus (66c)
PremiumThe FlyEditas Medicine reports Q1 EPS (76c), consensus (66c)
3d ago
EDIT
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
PremiumPress Releases
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
9d ago
EDIT
Editas Medicine, Bristol Myers extend alpha-beta T cell collaboration
PremiumThe Fly
Editas Medicine, Bristol Myers extend alpha-beta T cell collaboration
10d ago
BMY
EDIT
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
PremiumPress Releases
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
19d ago
EDIT
Editas Medicine management to meet with Oppenheimer
PremiumThe Fly
Editas Medicine management to meet with Oppenheimer
19d ago
EDIT
Editas Medicine management to meet with Oppenheimer
PremiumThe Fly
Editas Medicine management to meet with Oppenheimer
22d ago
EDIT
Editas Medicine price target raised to $16 from $11 at Citi
PremiumThe Fly
Editas Medicine price target raised to $16 from $11 at Citi
2M ago
EDIT
Editas Medicine price target raised to $11 from $10 at Barclays
PremiumThe FlyEditas Medicine price target raised to $11 from $10 at Barclays
2M ago
EDIT
Editas Medicine files automatic mixed securities shelf
PremiumThe Fly
Editas Medicine files automatic mixed securities shelf
2M ago
EDIT
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
PremiumPress Releases
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
2M ago
EDIT
Editas Medicine expects cash to fund operations into 2026
PremiumThe Fly
Editas Medicine expects cash to fund operations into 2026
2M ago
EDIT
Editas Medicine reports Q4 EPS (23c), consensus (54c)
PremiumThe Fly
Editas Medicine reports Q4 EPS (23c), consensus (54c)
2M ago
EDIT
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
PremiumPress Releases
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
3M ago
EDIT
Is EDIT a Buy, Before Earnings?
PremiumPre-Earnings
Is EDIT a Buy, Before Earnings?
3M ago
EDIT
Editas Medicine highlights 2024 anticipated milestones, strategic priorities
PremiumThe FlyEditas Medicine highlights 2024 anticipated milestones, strategic priorities
4M ago
EDIT
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
PremiumPress Releases
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
4M ago
EDIT
Editas Medicine price target raised by $7 at Evercore ISI, here’s why
PremiumThe Fly
Editas Medicine price target raised by $7 at Evercore ISI, here’s why
5M ago
EDIT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >